| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1414 | 2018 |
| Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases MA Incalza, R D'Oria, A Natalicchio, S Perrini, L Laviola, F Giorgino Vascular pharmacology 100, 1-19, 2018 | 1230 | 2018 |
| Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from … LJ Goodyear, F Giorgino, LA Sherman, J Carey, RJ Smith, GL Dohm The Journal of clinical investigation 95 (5), 2195-2204, 1995 | 731 | 1995 |
| Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use M Abdollahi, M Cushman, FR Rosendaal Thrombosis and haemostasis 89 (03), 493-498, 2003 | 614 | 2003 |
| The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis S Perrini, L Laviola, MC Carreira, A Cignarelli, A Natalicchio, F Giorgino Journal of Endocrinology 205, 201-210, 2010 | 450* | 2010 |
| Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis A Maran, C Crepaldi, A Tiengo, G Grassi, E Vitali, G Pagano, S Bistoni, ... Diabetes care 25 (2), 347-352, 2002 | 429 | 2002 |
| Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised … B Ludvik, F Giorgino, E Jódar, JP Frias, LF Landó, K Brown, R Bray, ... The Lancet 398 (10300), 583-598, 2021 | 418 | 2021 |
| The IGF-I signaling pathway L Laviola, A Natalicchio, F Giorgino Current pharmaceutical design 13 (7), 663-669, 2007 | 416 | 2007 |
| Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo) MM Ciccone, A Aquilino, F Cortese, P Scicchitano, M Sassara, E Mola, ... Vascular health and risk management, 297-305, 2010 | 405 | 2010 |
| Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies F Giorgino, L Laviola, JW Eriksson Acta Physiologica Scandinavica 183 (1), 13-30, 2005 | 348 | 2005 |
| The role of oxidative stress in cardiac disease: from physiological response to injury factor R D’Oria, R Schipani, A Leonardini, A Natalicchio, S Perrini, A Cignarelli, ... Oxidative medicine and cellular longevity 2020 (1), 5732956, 2020 | 285 | 2020 |
| Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin … O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ... The lancet Diabetes & endocrinology 5 (11), 887-897, 2017 | 280 | 2017 |
| Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study MT Schram, N Chaturvedi, C Schalkwijk, F Giorgino, P Ebeling, JH Fuller, ... Diabetes care 26 (7), 2165-2173, 2003 | 278 | 2003 |
| Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle LJ Goodyear, F Giorgino, TW Balon, G Condorelli, RJ Smith American Journal of Physiology-Endocrinology and Metabolism 268 (5), E987-E995, 1995 | 276 | 1995 |
| Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2) F Giorgino, M Benroubi, JH Sun, AG Zimmermann, V Pechtner Diabetes care 38 (12), 2241-2249, 2015 | 274 | 2015 |
| Insulin receptor expression and function in human breast cancer cell lines G Milazzo, F Giorgino, G Damante, C Sung, MR Stampfer, R Vigneri, ... Cancer research 52 (14), 3924-3930, 1992 | 274 | 1992 |
| Cross‐Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity A Leonardini, L Laviola, S Perrini, A Natalicchio, F Giorgino PPAR research 2009 (1), 818945, 2009 | 271* | 2009 |
| Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. F Giorgino, A Almahfouz, LJ Goodyear, RJ Smith The Journal of clinical investigation 91 (5), 2020-2030, 1993 | 252 | 1993 |
| Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis M Castellana, E Conte, A Cignarelli, S Perrini, A Giustina, L Giovanella, ... Reviews in Endocrine and Metabolic Disorders 21 (1), 5-16, 2020 | 215 | 2020 |
| Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) M Caprio, M Infante, E Moriconi, A Armani, A Fabbri, G Mantovani, ... Journal of endocrinological investigation 42, 1365-1386, 2019 | 210 | 2019 |
Sebastio PerriniUniversity of Bari在 uniba.it 的电子邮件经过验证
